MENU
RLYB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rallybio (RLYB) Ownership - Who owns Rallybio?
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more
Profile
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
24.64M
P/E Ratio
N/A
Total Cash
45.75M
Projected Growth
N/A
Total Debt
58K
Revenue
761K
Risk (Beta)
-1.16
Dividend Yield
N/A
Total Cash/Share
1.09
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
RLYB
Capitalization
24.6M
P/E Ratio
N/A
Risk (Beta)
-1.16
Dividend Yield
N/A
Total Cash
45.7M
Total Cash/Share
1.09
Total Debt
58K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
761K
ROE
N/A
Book Value
46M
P/B Ratio
0.54
Cash Flow
N/A
Earnings
-0.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
9.98
Current Revenue Per Employee
10600.00
Dividends Per Share - Security
N/A
EBITDA
-43.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-58.08
Shares Held By Institutions
19.7M
Shares Outstanding - Current
41.8M
Total Liabilities
5.04M
Total Volume MTD
N/A
Value
1
Gain YTD
-38.573
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLYB showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com